These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 33962579)
21. Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [ Buteau JP; Moon D; Fahey MT; Roberts MJ; Thompson J; Murphy DG; Papa N; Mitchell C; De Abreu Lourenco R; Dhillon HM; Kasivisvanathan V; Francis RJ; Stricker P; Agrawal S; O'Brien J; McVey A; Sharma G; Levy S; Ayati N; Nguyen A; Lee SF; Pattison DA; Sivaratnam D; Frydenberg M; Du Y; Titus J; Lee ST; Ischia J; Jack G; Hofman MS; Emmett L Eur Urol Oncol; 2024 Jun; 7(3):544-552. PubMed ID: 38061976 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy. Henkenberens C; Oehus AK; Derlin T; Bengel F; Ross TL; Kuczyk MA; Janssen S; Christiansen H; von Klot CAJ Strahlenther Onkol; 2020 Nov; 196(11):1006-1017. PubMed ID: 32399639 [TBL] [Abstract][Full Text] [Related]
23. Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center Study. Lenis AT; Pooli A; Lec PM; Sadun TY; Johnson DC; Lebacle C; Fendler WP; Eiber M; Czernin J; Reiter RE; Calais J Eur Urol Oncol; 2022 Oct; 5(5):544-552. PubMed ID: 32958451 [TBL] [Abstract][Full Text] [Related]
24. A Multicenter Prospective Clinical Trial of McCarthy M; Francis R; Tang C; Watts J; Campbell A Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):801-808. PubMed ID: 30890448 [TBL] [Abstract][Full Text] [Related]
25. Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Is Associated with Improved Oncological Outcome in Men Treated with Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer. Meijer D; Eppinga WSC; Mohede RM; Vanneste BGL; Meijnen P; Meijer OWM; Daniels LA; van den Bergh RCN; Lont AP; Ettema RH; Oudshoorn FHK; van Leeuwen PJ; van der Poel HG; Donswijk ML; Oprea-Lager DE; Schaake EE; Vis AN Eur Urol Oncol; 2022 Apr; 5(2):146-152. PubMed ID: 35074282 [TBL] [Abstract][Full Text] [Related]
26. UpFrontPSMA: a randomized phase 2 study of sequential Dhiantravan N; Emmett L; Joshua AM; Pattison DA; Francis RJ; Williams S; Sandhu S; Davis ID; Vela I; Neha N; Bressel M; Murphy DG; Hofman MS; Azad AA BJU Int; 2021 Sep; 128(3):331-342. PubMed ID: 33682320 [TBL] [Abstract][Full Text] [Related]
27. Pelvic lymph node mapping in prostate cancer: examining the impact of PSMA PET/CT on radiotherapy decision-making in patients with node-positive disease. Furman B; Falick Michaeli T; Den R; Ben Haim S; Popovtzer A; Wygoda M; Blumenfeld P Cancer Imaging; 2024 Jul; 24(1):96. PubMed ID: 39075567 [TBL] [Abstract][Full Text] [Related]
28. Detection of prostate cancer with Bodar YJL; Jansen BHE; van der Voorn JP; Zwezerijnen GJC; Meijer D; Nieuwenhuijzen JA; Boellaard R; Hendrikse NH; Hoekstra OS; van Moorselaar RJA; Oprea-Lager DE; Vis AN World J Urol; 2021 Jul; 39(7):2439-2446. PubMed ID: 33079250 [TBL] [Abstract][Full Text] [Related]
29. Changes in Management After Ng M; Guerrieri M; Wong LM; Taubman K; Sutherland T; Benson A; Byrne G; Koschel S; Yap K; Starmans M; Ong G; Macleod C; Foo M; Chao M J Nucl Med; 2022 Sep; 63(9):1343-1348. PubMed ID: 35058320 [TBL] [Abstract][Full Text] [Related]
30. PSMA-PET/CT-Guided Intensification of Radiation Therapy for Prostate Cancer (PSMAgRT): Findings of Detection Rate, Effect on Cancer Management, and Early Toxicity From a Phase 2 Randomized Controlled Trial. Petit C; Delouya G; Taussky D; Barkati M; Lambert C; Beauchemin MC; Clavel S; Mok G; Paré AG; Nguyen TV; Duplan D; Keu KV; Saad F; Juneau D; Ménard C Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):779-787. PubMed ID: 36639035 [TBL] [Abstract][Full Text] [Related]
37. LUNAR: a randomized Phase 2 study of Ma TM; Czernin J; Felix C; Alano R; Wilhalme H; Valle L; Steinberg ML; Dahlbom M; Reiter RE; Rettig MB; Cao M; Calais J; Kishan AU BJU Int; 2023 Jul; 132(1):65-74. PubMed ID: 36797449 [TBL] [Abstract][Full Text] [Related]
38. Prospective Comparison of PET Imaging with PSMA-Targeted Rowe SP; Li X; Trock BJ; Werner RA; Frey S; DiGianvittorio M; Bleiler JK; Reyes DK; Abdallah R; Pienta KJ; Gorin MA; Pomper MG J Nucl Med; 2020 Feb; 61(2):183-188. PubMed ID: 31451492 [TBL] [Abstract][Full Text] [Related]